A Study Investigating the Efficacy, Safety, and PK Profile of ANB020 Administered to Adult Subjects With Moderate-to-Severe AD
Clinical Trial ID: NCT03533751
Learn about this trial.
Check the eligibility requirements, study details, and more.
Clinical Trial ID: NCT03533751
Check the eligibility requirements, study details, and more.